Fundraising FoxGreen D Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
NanoPathnanopath.comin𝕏Jun 2022
Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health.
BiotechFemTechMedical DevicesCambridge, US
Alison Burklund(Executive Officer, Director)inAmogha Tadimety(Executive Officer, Director)in
BoardAaron Sandoski(Director)inJeff Crowe(Director)in
Co-investorsAlumni VenturesNorwest Venture PartnersService Provider CapitalSV Health InvestorsUndeterred CapitalGingerbread Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.